50-152-60

CD267 (TACI) Monoclonal Antibody (ebio8F10-3), APC, eBioscience™, Invitrogen™

Manufacturer: Fischer Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 50-152-60-Each-of-1 In Stock ₹ 20,292.00

50-152-60 - Each of 1

₹ 20,292.00

In Stock

Quantity

1

Base Price: ₹ 20,292.00

GST (18%): ₹ 3,652.56

Total Price: ₹ 23,944.56

Antigen

CD267 (TACI)

Classification

Monoclonal

Concentration

0.2 mg/mL

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Accession No.

Q9ET35

Gene Symbols

TNFRSF13B

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

57916

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

ebio8F10-3

Conjugate

APC

Gene

TNFRSF13B

Gene Alias

1200009E08Rik; CD267; CVID; CVID2; IGAD2; NEWGENE_1595998; RYZN; TACI; TNF receptor superfamily member 13B; Tnfrsf13b; TNFRSF14B; transmembrane activator and calcium-modulating and cyclophilin ligand interactor; transmembrane activator and CAML interactor; tumor necrosis factor receptor 13B; tumor necrosis factor receptor superfamily member 13B; tumor necrosis factor receptor superfamily, member 13B

Host Species

Rat

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Mouse

Product Type

Antibody

Isotype

IgG2a κ

Related Products

Img

Fischer Scientific

50-152-59

--

Img

Fischer Scientific

50-154-87

--

Img

Fischer Scientific

50-150-96

--

Img

Fischer Scientific

50-154-90

--

Img

Fischer Scientific

50-150-95

--

Img

Fischer Scientific

50-149-60

--

Img

Fischer Scientific

50-150-98

--

Img

Fischer Scientific

50-150-97

--

Description

  • Description: The monoclonal antibody eBio8F10.3 recognizes TACI (Transmembrane Activator and Calcium-modulator and CAML Interactor) also known as CD267
  • TACI is a type III membrane protein belonging to the TNF receptor superfamily
  • The ligand for TACI has been shown to be BAFF (BLyS) and APRIL
  • TACI is expressed on the surface of a subset of maturing splenic B cells of the transitional type termed T2
  • Genetic studies have shown a role for TACI in both stimulation and inhibition of B cell proliferation
  • This actual role for TACI in the mouse has still not been determined
  • Recently human TACI has been shown to have repressive activities which inhibit BAFF-R function
  • Applications Reported: This ebio8F10-3 antibody has been reported for use in flow cytometric analysis
  • Applications Tested: This ebio8F10-3 antibody has been tested by flow cytometric analysis of mouse splenocytes
  • This can be used at less than or equal to 0.25 μg per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest
  • Excitation: 633-647 nm; Emission: 660 nm; Laser: Red Laser
  • Filtration: 0.2 μm post-manufacturing filtered
  • Members in the TNF superfamily regulate immune responses and induce apoptosis
  • Two novel members in the TNF family were recently identified and designated BAFF/BLyS/TALL-1/THANK/zTNF4 and April/TALL-2, respectively
  • BAFF was characterized as a B cell activator since it induced B cell proliferation and immunoglobulin secretion
  • April regulates immunological and non-immunological cell growth
  • Three receptors, BCMA, TACI, and BAFF-R, for BAFF and April were recently identified
  • TACI, like BCMA, binds BAFF and April
  • TACI and its ligands regulate humoral immune responses, activate NF-kappa-B and c-jun N-terminal kinase, and are involved in B cell associated autoimmune diseases.